Mahmud YusupovNov 1, 20221 min readThis Week In NewsTirzepatide granted UK marketing authorisation for type 2 diabeteshttps://www.pulsetoday.co.uk/news/clinical-areas/diabetes/tirzepatide-granted-uk-marketing-authorisation-for-type-2-diabetes/ Steve Barclay reappointed as health secretaryhttps://www.pulsetoday.co.uk/news/breaking-news/steve-barclay-reappointed-as-health-secretary/ NHS hits 10 million booster milestonehttps://www.england.nhs.uk/2022/10/nhs-hits-10-million-booster-milestone/ Government decision on tougher online pharmacy regulation expected ‘shortly’https://pharmaceutical-journal.com/article/news/government-decision-on-tougher-online-pharmacy-regulation-expected-shortly New Electronic Repeat Dispensing guidancehttps://psnc.org.uk/our-news/new-electronic-repeat-dispensing-guidance/
Tirzepatide granted UK marketing authorisation for type 2 diabeteshttps://www.pulsetoday.co.uk/news/clinical-areas/diabetes/tirzepatide-granted-uk-marketing-authorisation-for-type-2-diabetes/ Steve Barclay reappointed as health secretaryhttps://www.pulsetoday.co.uk/news/breaking-news/steve-barclay-reappointed-as-health-secretary/ NHS hits 10 million booster milestonehttps://www.england.nhs.uk/2022/10/nhs-hits-10-million-booster-milestone/ Government decision on tougher online pharmacy regulation expected ‘shortly’https://pharmaceutical-journal.com/article/news/government-decision-on-tougher-online-pharmacy-regulation-expected-shortly New Electronic Repeat Dispensing guidancehttps://psnc.org.uk/our-news/new-electronic-repeat-dispensing-guidance/
Comments